Bewell Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.96 M
as on 16-11-2024
- Company Age 37 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 16.79 Cr
as on 16-11-2024
- Revenue %
(FY 2023)
- Profit 22.15%
(FY 2023)
- Ebitda 62.38%
(FY 2023)
- Net Worth -3.90%
(FY 2023)
- Total Assets -0.38%
(FY 2023)
About Bewell Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.96 M.
The company has closed loans amounting to ₹16.79 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Krishna Sadani and Sangeeta Sadani serve as directors at the Company.
- CIN/LLPIN
U27201WB1987PTC042976
- Company No.
042976
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 1987
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bewell Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Sadani  | Additional Director | 01-Sep-2015 | Current |
| Sangeeta Sadani | Director | 01-Sep-2015 | Current |
Financial Performance of Bewell Pharmaceuticals.
Bewell Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 22.15% increase in profit. The company's net worth dipped by a decrease of 3.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bewell Pharmaceuticals?
In 2023, Bewell Pharmaceuticals had a promoter holding of 88.54% and a public holding of 11.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aarogyam Packaging Solutions Private LimitedActive 12 years 4 monthsSangeeta Sadani is a mutual person
Bewell Labs Private LimitedActive 25 years 4 monthsKrishna Sadani and Sangeeta Sadani are mutual person
- Vaishali (India) LimitedActive 26 years 8 months
Krishna Sadani and Sangeeta Sadani are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 03 Jun 2011 | ₹12.45 Cr | Satisfied |
Allahabad Bank Creation Date: 13 Oct 2010 | ₹3.34 Cr | Satisfied |
State Bank Of India Creation Date: 16 Jun 2005 | ₹10.00 M | Satisfied |
How Many Employees Work at Bewell Pharmaceuticals?
Unlock and access historical data on people associated with Bewell Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bewell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bewell Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
